When each of these peptides at 3 nM min-1 kg-1 body weight were infused subcutaneously for 28 days in athymic mice bearing human pancreatic adenocarcinomas, ANP eliminated 80% the human pancreatic cancers [40]. This evidence concerns the gene NPPA and familial pancreatic carcinoma.